Skip to content
DataLookout
Menu

EUQ13NCT07119606

Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Recruitment opened
    • Eligibility criteria expanded, about 4 words
    • Study description revised
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Better Understanding the Clinical Variability of the Phelan-McDermid Syndrome
Timeframe: 18 months

Arms and interventions

SHANK3 MutationExperimental

Diagnostic tests: SHANK3 mutation

Sites

1 site in 1 country

  • Robert Debré HospitalParis, Ap-hp / DRCI, France